131 related articles for article (PubMed ID: 28388532)
1. Cooperative down-regulation of ribosomal protein L10 and NF-κB signaling pathway is responsible for the anti-proliferative effects by DMAPT in pancreatic cancer cells.
Shi C; Wang Y; Guo Y; Chen Y; Liu N
Oncotarget; 2017 May; 8(21):35009-35018. PubMed ID: 28388532
[TBL] [Abstract][Full Text] [Related]
2. NF-κB-dependent and -independent epigenetic modulation using the novel anti-cancer agent DMAPT.
Nakshatri H; Appaiah HN; Anjanappa M; Gilley D; Tanaka H; Badve S; Crooks PA; Mathews W; Sweeney C; Bhat-Nakshatri P
Cell Death Dis; 2015 Jan; 6(1):e1608. PubMed ID: 25611383
[TBL] [Abstract][Full Text] [Related]
3. Dimethylamino parthenolide enhances the inhibitory effects of gemcitabine in human pancreatic cancer cells.
Holcomb BK; Yip-Schneider MT; Waters JA; Beane JD; Crooks PA; Schmidt CM
J Gastrointest Surg; 2012 Jul; 16(7):1333-40. PubMed ID: 22618517
[TBL] [Abstract][Full Text] [Related]
4. DMAPT inhibits NF-κB activity and increases sensitivity of prostate cancer cells to X-rays in vitro and in tumor xenografts in vivo.
Mendonca MS; Turchan WT; Alpuche ME; Watson CN; Estabrook NC; Chin-Sinex H; Shapiro JB; Imasuen-Williams IE; Rangel G; Gilley DP; Huda N; Crooks PA; Shapiro RH
Free Radic Biol Med; 2017 Nov; 112():318-326. PubMed ID: 28782644
[TBL] [Abstract][Full Text] [Related]
5. Dimethylaminoparthenolide and gemcitabine: a survival study using a genetically engineered mouse model of pancreatic cancer.
Yip-Schneider MT; Wu H; Stantz K; Agaram N; Crooks PA; Schmidt CM
BMC Cancer; 2013 Apr; 13():194. PubMed ID: 23590467
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of NF-κB and DNA double-strand break repair by DMAPT sensitizes non-small-cell lung cancers to X-rays.
Estabrook NC; Chin-Sinex H; Borgmann AJ; Dhaemers RM; Shapiro RH; Gilley D; Huda N; Crooks P; Sweeney C; Mendonca MS
Free Radic Biol Med; 2011 Dec; 51(12):2249-58. PubMed ID: 22019440
[TBL] [Abstract][Full Text] [Related]
7. Parthenolide and DMAPT induce cell death in primitive CML cells through reactive oxygen species.
Flores-Lopez G; Moreno-Lorenzana D; Ayala-Sanchez M; Aviles-Vazquez S; Torres-Martinez H; Crooks PA; Guzman ML; Mayani H; Chávez-González A
J Cell Mol Med; 2018 Oct; 22(10):4899-4912. PubMed ID: 30079458
[TBL] [Abstract][Full Text] [Related]
8. Ribosomal protein L10 in mitochondria serves as a regulator for ROS level in pancreatic cancer cells.
Yang J; Chen Z; Liu N; Chen Y
Redox Biol; 2018 Oct; 19():158-165. PubMed ID: 30172100
[TBL] [Abstract][Full Text] [Related]
9. A water-soluble parthenolide analogue suppresses in vivo prostate cancer growth by targeting NFkappaB and generating reactive oxygen species.
Shanmugam R; Kusumanchi P; Cheng L; Crooks P; Neelakantan S; Matthews W; Nakshatri H; Sweeney CJ
Prostate; 2010 Jul; 70(10):1074-86. PubMed ID: 20209491
[TBL] [Abstract][Full Text] [Related]
10. A novel natural product, britanin, inhibits tumor growth of pancreatic cancer by suppressing nuclear factor-κB activation.
Li K; Zhou Y; Chen Y; Zhou L; Liang J
Cancer Chemother Pharmacol; 2020 Apr; 85(4):699-709. PubMed ID: 32185482
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of dimethylaminoparthenolide and sulindac in combination with gemcitabine in a genetically engineered mouse model of pancreatic cancer.
Yip-Schneider MT; Wu H; Hruban RH; Lowy AM; Crooks PA; Schmidt CM
Pancreas; 2013 Jan; 42(1):160-7. PubMed ID: 22699205
[TBL] [Abstract][Full Text] [Related]
12. Flavonoid apigenin modified gene expression associated with inflammation and cancer and induced apoptosis in human pancreatic cancer cells through inhibition of GSK-3β/NF-κB signaling cascade.
Johnson JL; de Mejia EG
Mol Nutr Food Res; 2013 Dec; 57(12):2112-27. PubMed ID: 23943362
[TBL] [Abstract][Full Text] [Related]
13. Effect of celecoxib and the novel anti-cancer agent, dimethylamino-parthenolide, in a developmental model of pancreatic cancer.
Yip-Schneider MT; Wu H; Njoku V; Ralstin M; Holcomb B; Crooks PA; Neelakantan S; Sweeney CJ; Schmidt CM
Pancreas; 2008 Oct; 37(3):e45-53. PubMed ID: 18815538
[TBL] [Abstract][Full Text] [Related]
14. Hyperoside induces apoptosis and inhibits growth in pancreatic cancer via Bcl-2 family and NF-κB signaling pathway both in vitro and in vivo.
Li Y; Wang Y; Li L; Kong R; Pan S; Ji L; Liu H; Chen H; Sun B
Tumour Biol; 2016 Jun; 37(6):7345-55. PubMed ID: 26676634
[TBL] [Abstract][Full Text] [Related]
15. A water soluble parthenolide analog suppresses in vivo tumor growth of two tobacco-associated cancers, lung and bladder cancer, by targeting NF-κB and generating reactive oxygen species.
Shanmugam R; Kusumanchi P; Appaiah H; Cheng L; Crooks P; Neelakantan S; Peat T; Klaunig J; Matthews W; Nakshatri H; Sweeney CJ
Int J Cancer; 2011 May; 128(10):2481-94. PubMed ID: 20669221
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide.
Patel NM; Nozaki S; Shortle NH; Bhat-Nakshatri P; Newton TR; Rice S; Gelfanov V; Boswell SH; Goulet RJ; Sledge GW; Nakshatri H
Oncogene; 2000 Aug; 19(36):4159-69. PubMed ID: 10962577
[TBL] [Abstract][Full Text] [Related]
17. Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway.
Liu X; Xiao XY; Shou QY; Yan JF; Chen L; Fu HY; Wang JC
J Ethnopharmacol; 2016 Dec; 193():538-545. PubMed ID: 27686271
[TBL] [Abstract][Full Text] [Related]
18. Curcumin inhibits cell proliferation and promotes apoptosis in human osteoclastoma cell through MMP-9, NF-κB and JNK signaling pathways.
Cao F; Liu T; Xu Y; Xu D; Feng S
Int J Clin Exp Pathol; 2015; 8(6):6037-45. PubMed ID: 26261481
[TBL] [Abstract][Full Text] [Related]
19. The inhibition of cell proliferation and induction of apoptosis in pancreatic ductal adenocarcinoma cells by verrucarin A, a macrocyclic trichothecene, is associated with the inhibition of Akt/NF-кB/mTOR prosurvival signaling.
Deeb D; Gao X; Liu Y; Zhang Y; Shaw J; Valeriote FA; Gautam SC
Int J Oncol; 2016 Sep; 49(3):1139-47. PubMed ID: 27573873
[TBL] [Abstract][Full Text] [Related]
20. The ufmylation modification of ribosomal protein L10 in the development of pancreatic adenocarcinoma.
Wang K; Chen S; Wu Y; Wang Y; Lu Y; Sun Y; Chen Y
Cell Death Dis; 2023 Jun; 14(6):350. PubMed ID: 37280198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]